Literature DB >> 3146628

Expression of endothelial cell markers PAL-E and EN-4 and Ia-antigens in Kaposi's sarcoma.

H Nadimi1, S Saatee, A Armin, P D Toto.   

Abstract

Eleven biopsy specimens of Kaposi's sarcoma (KS) removed from the skin and oral mucosa were examined immunohistochemically with monoclonal antibodies PAL-E and EN-4, specific for human vascular endothelial cells, and with LN-3 monoclonal antibody reactive with immune-associated (Ia) antigens in the HLA-DR locus. The early lesions of KS, corresponding to the patch phase, contained hyperplastic venules and an increased number of lymphatic capillaries. The lymphatic capillary endothelium was reactive with EN-4, whereas, PAL-E reacted only with blood vessel endothelial cells. The spindle cells, like lymphatic endothelial cells, were non-reactive with PAL-E but showed positive reaction with EN-4 antibodies. The observed morphologic pattern of vasculogenesis and the demonstrated immune-reactivity in KS support an origin from the venule-lymphatic junction. This is an aberrant pattern but reminiscent of normal embryonal lymphatic channel development. The lymphatic capillaries and vascular slits were nonreactive with LN-3 antibody, but it was positive on cell membranes in a number of spindle cells, suggesting the focal expression of Ia-antigens.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3146628     DOI: 10.1111/j.1600-0714.1988.tb01307.x

Source DB:  PubMed          Journal:  J Oral Pathol        ISSN: 0300-9777


  8 in total

1.  HIV-associated Kaposi's sarcoma: new developments in epidemiology and molecular pathology.

Authors:  W K Roth
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Characterization of EN4 monoclonal antibody: a reagent with CD31 specificity.

Authors:  V L Burgio; S Zupo; S Roncella; M Zocchi; L P Ruco; C D Baroni
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

3.  Lymphatic differentiation in classic Kaposi's sarcoma: patterns of D2-40 immunoexpression in the course of tumor progression.

Authors:  Nilufer Onak Kandemir; Figen Barut; Banu Dogan Gun; Sevinc Hallac Keser; Nimet Karadayi; Mustafa Gun; Sukru Oguz Ozdamar
Journal:  Pathol Oncol Res       Date:  2011-04-10       Impact factor: 3.201

4.  Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi's sarcoma herpes virus.

Authors:  Jaehyuk Yoo; Jinjoo Kang; Ha Neul Lee; Berenice Aguilar; Darren Kafka; Sunju Lee; Inho Choi; Juneyong Lee; Swapnika Ramu; Juergen Haas; Chester J Koh; Young-Kwon Hong
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

5.  Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.

Authors:  N Dupin; C Fisher; P Kellam; S Ariad; M Tulliez; N Franck; E van Marck; D Salmon; I Gorin; J P Escande; R A Weiss; K Alitalo; C Boshoff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

6.  Characterization of c-Kit expression and activation in KSHV-infected endothelial cells.

Authors:  Janet L Douglas; Jill G Whitford; Ashlee V Moses
Journal:  Virology       Date:  2009-06-06       Impact factor: 3.616

7.  Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation.

Authors:  Janet L Douglas; Jean K Gustin; Ashlee V Moses; Bruce J Dezube; Liron Pantanowitz
Journal:  Transl Biomed       Date:  2010

Review 8.  Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesis.

Authors:  R V Stan
Journal:  J Cell Mol Med       Date:  2007 Jul-Aug       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.